BD (Becton, Dickinson and Company) announced it has completed the acquisition of privately held Scanwell Health, a developer of smartphone-enabled at-home medical tests.
BD collaborated with Scanwell to develop the app used with the recently launched BD Veritor At-Home COVID-19 Test, which has received emergency use authorization from the U.S. Food and Drug Administration (FDA). The test uses the phone's camera to capture the image of the test, which the app then analyzes, interprets, and provides a digital display of results.
BD said, “Scanwell will become the foundational digital platform upon which BD plans to develop at-home diagnostic tests for a range of infectious diseases including COVID-19/influenza A+B, group A strep and additional menu for detecting infections and managing chronic disease.”
